Patents by Inventor Neil Douglas Brewis

Neil Douglas Brewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Uses of transport proteins
    Publication number: 20040142900
    Abstract: This invention relates to uses of transport-active proteins, particularly of proteins and fusion polypeptides with the function of VP22, for control of the cell cycle, particularly in the reduction of the proliferating activity of proliferating cells.
    Type: Application
    Filed: February 26, 2004
    Publication date: July 22, 2004
    Applicant: Phogen Limited
    Inventors: Peter Francis Joseph O'Hare, Nadia Michelle Normand, Neil Douglas Brewis, Anne Phelan
  • Uses of transport proteins
    Patent number: 6734167
    Abstract: This invention relates to uses of transport-active proteins, particularly of proteins and fusion polypeptides with the function of VP22, for control of the cell cycle, particularly in the reduction of the proliferating activity of proliferating cells.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: May 11, 2004
    Assignee: Phogen Limited
    Inventors: Peter Francis Joseph O'Hare, Nadia Michelle Normand, Neil Douglas Brewis, Anne Phelan
  • Uses of transport proteins
    Publication number: 20020155988
    Abstract: This invention relates to uses of transport-active proteins, particularly of proteins and fusion polypeptides with the function of VP22, for control of the cell cycle, particularly in the reduction of the proliferating activity of proliferating cells.
    Type: Application
    Filed: December 20, 2000
    Publication date: October 24, 2002
    Inventors: Peter Francis Joseph O'Hare, Nadia Michelle Normand, Neil Douglas Brewis, Anne Phelan
  • Delivery of substances to cells
    Publication number: 20020142960
    Abstract: Aggregates comprising VP22 protein and oligonucleotides or polynucleotides can be used together with a disaggregating agent (simultaneously or sequentially) to treat target cells by delivery of molecules to the cells and/or to prevent cell proliferation and/or to kill cells.
    Type: Application
    Filed: September 7, 2001
    Publication date: October 3, 2002
    Applicant: Phogen Limited
    Inventors: Peter Francis Joseph O'Hare, Neil Douglas Brewis, Nadia Michelle Normand, Kavitha Renga Sunassee